Which stocks in any sector do Indian mutual fund managers prefer most? — June 2026 data
| # | Stock Name | No. of MFs Holding | Avg Weight (%) | Total MF Value (Cr) |
|---|---|---|---|---|
| 41 | AstraZeneca Pharma India Limited | 26 funds | 0.96% | ₹1,209 Cr |
| 42 | Orchid Pharma Limited | 26 funds | 0.69% | ₹645 Cr |
| 43 | Shilpa Medicare Ltd | 24 funds | 0.70% | ₹479 Cr |
| 44 | Procter & Gamble Health Limited | 22 funds | 1.83% | ₹946 Cr |
| 45 | Marksans Pharma Limited | 21 funds | 1.09% | ₹519 Cr |
| 46 | Akums Drugs and Pharmaceuticals Limited | 21 funds | 0.67% | ₹875 Cr |
| 47 | Sanofi India Limited | 20 funds | 0.45% | ₹693 Cr |
| 48 | SUPRIYA LIFESCIENCE LIMITED | 18 funds | 0.75% | ₹106 Cr |
| 49 | Alivus Life Sciences | 18 funds | 0.75% | ₹440 Cr |
| 50 | Senores Pharmaceuticals Ltd | 16 funds | 1.03% | ₹402 Cr |
| 51 | Strides Pharma Science Limited | 15 funds | 0.33% | ₹316 Cr |
| 52 | Innova Captab Limited | 14 funds | 0.76% | ₹514 Cr |
| 53 | Aarti Pharmalabs Limited | 13 funds | 0.24% | ₹38 Cr |
| 54 | Advanced Enzyme Technologies Limited | 13 funds | 0.27% | ₹63 Cr |
| 55 | Aarti Drugs Ltd | 12 funds | 0.30% | ₹348 Cr |
| 56 | FDC Limited | 11 funds | 0.72% | ₹415 Cr |
| 57 | Sequent Scientific Limited | 11 funds | 0.35% | ₹44 Cr |
| 58 | Gufic Biosciences Ltd. | 10 funds | 0.42% | ₹130 Cr |
| 59 | Sun Pharma Advanced Research Company Limited | 9 funds | 0.07% | ₹6 Cr |
| 60 | Indoco Remedies Ltd | 9 funds | 0.51% | ₹278 Cr |
The table above ranks the top 20 stocks in the Pharmaceuticals & Biotechnology sector by the number of Indian mutual fund schemes holding them as of June 2026. When a large number of fund managers independently choose the same stock, it is a powerful signal of institutional conviction — these are the stocks that professional money managers believe in most.
A stock held by 200+ mutual funds means that hundreds of fund managers — each doing their own independent research — have concluded that this stock deserves a place in their portfolio. This collective wisdom is one of the most reliable indicators of a stock's quality within its sector. The average weight shows how much of their portfolio each fund typically allocates to the stock, and the total MF value shows the combined rupee investment across all funds holding it.
All data is sourced from monthly portfolio disclosures that every AMFI-registered mutual fund is required to publish. RightAdvise compiles and analyses this data across 1,100+ active fund schemes to give you a clear, unbiased view of where professional fund managers are investing in the Pharmaceuticals & Biotechnology sector. Click any stock name in the table to see which specific funds hold it and in what proportion.